New Jersey's Public Health Insurance System on the Brink

New Jersey's public health insurance system is struggling under a mountain of debt and skyrocketing costs, with premium hikes reaching as high as 36.5% and prescription drug costs exceeding 50%. The state's politicians are quick to point fingers, but the core problem lies in a system designed to serve bureaucrats and middlemen, not patients. A recent analysis by Aon highlights the need for fundamental change, including price transparency, consumer control, and competition in the pharmacy benefit manager system.

Key Takeaways:

• The State Health Benefits Plan and the School Employees' Health Benefits Plan in New Jersey are hemorrhaging money, with premium hikes reaching 36.5% and prescription drug costs exceeding 50%.
• The core problem lies in a system designed to serve bureaucrats and middlemen, not patients, and is built on a model of opacity and lack of transparency.
• Unleashing price transparency by forcing hospitals, insurers, and PBMs to post real prices up front can create accountability, empower patients, and expose price-gouging.
• Letting consumers control their health care dollars through tax-free health savings accounts, direct primary care memberships, and defined-contribution plans can give public workers more control over their health care benefits.
• Breaking up the PBM monopoly and reforming or replacing the PBM system with transparent pharmacy marketplaces can bring competition and reduce cartel pricing.
• Drug prices are out of control, with New Jersey's public plans now spending more on prescription drugs than on inpatient hospital care, due to a broken pricing system that hides true costs.
• Reforming the benefits, coverage mandates, and reimbursement models set by government boards can free insurers to compete based on outcomes, service, and cost.
• Ending recurring crisis budgeting and moving to sustainable, consumer-driven budgeting that rewards prevention, shopping, and cost control can create a more responsible and efficient system.
• Treating patients like customers by allowing them to customize care, reward providers who deliver real value, and get coverage that travels with them can create a more responsive and effective system.

Statistics:

• Premium hikes reached 36.5% for New Jersey local government workers (Source: Aon analysis)
• Prescription drug costs exceeded 50% (Source: Aon analysis)
• New Jersey's public plans spent more on prescription drugs than on inpatient hospital care (Source: Aon analysis)
• The cost of a single GLP-1 like Wegovy or Ozempic can range from $1,000 to $6,000 per year (Source: Steve Forbes)
• The PBM system in the United States costs patients, employers, and government programs an estimated $30 billion per year in excess spending (Source: Steve Forbes)

Sources:

• Aon analysis of the State Health Benefits Plan and the School Employees' Health Benefits Plan
• Steve Forbes, "New Jersey's Public Health Insurance System on the Brink" (Forbes Media)
• Steve Forbes, "The Price of Government-Run Healthcare" (Forbes Media)